• Follow the Money: Eikon Advances Multiple Programs, Multi-Payload Antibody-Drug Conjugate, More

    Clinical Research News | Eikon will advance its programs aimed to treat advanced melanoma, as well as breast, ovarian, prostate, pancreatic, and brain cancers; Callio launches with innovative multi-payload programs designed to maximize therapeutic benefit for cancer patients; and more.

    Mar 26, 2025

  • Flatiron Health Pioneers International Patient-Level Data Sharing for Oncology Research

    Clinical Research News | Flatiron Health is breaking new ground in oncology research by enabling patient-level real-world data (RWD) sharing across four countries—U.S., UK, Germany, and Japan. Despite initial skepticism, researchers are now eager to access these harmonized electronic health record (EHR) datasets in a secure, cloud-based environment.

    Mar 20, 2025

  • AI Platform Aims to Translate Trial Results at the Point of Care

    Clinical Research News | For medical oncologists, the clinical quandary in treating patients is whether a newly marketed agent or drug cocktail will work as well as it did for the average cancer patient in a landmark clinical trial.

    Mar 18, 2025

  • Navigating the Real-World: How to Better Utilize Real-World Evidence

    Clinical Research News | Interest in Real-World Evidence (RWE) studies continues to grow. Data from ClinicalTrials.gov shows the number of RWE studies registered has increased dramatically since 2005, particularly in the last seven years. But what is RWE, how is it used in clinical trials and how can we work with Real-World Data (RWD) to produce RWE?

    Mar 14, 2025

  • Jumo Health Broadening its Health Equity Approach

    Clinical Research News | Jumo Health launched a suite of services to drive health equity in clinical trials in 2023 via a collaboration with I Choose Life Foundation, a nonprofit dedicated to addressing health disparities in the African American community. It helped the company pilot its first community engagement event in the form of a workshop to train local business and faith leaders to serve as trusted messengers of information about clinical research and the point-of-care experience.

    Mar 12, 2025

  • Black Women with Breast Cancer Now Lead Champions of Clinical Trials

    Clinical Research News | For Black women diagnosed with breast cancer, the grim reality is that they are 41% more likely to die of the disease than white women. African American women are disproportionately affected by triple negative breast cancer (TNBC), the most aggressive form of the disease, but that only partially explains the discrepancy in the mortality rate.

    Mar 11, 2025

  • The Scope of Things: Sharing Patient Insights, Absence of Pregnant Women in Clinical Trials, Boosting Cancer Vaccine Work, More

    Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz delivers the news on how an AI-powered trial screening tool outperformed human research staff, a strategy report on boosting cancer vaccine work, the issue of continued absence of pregnant women in clinical trials, and more. Plus, Rare Patient Voice founder and president Wes Michael also joins in to talk about how his company is connecting people undertaking research studies with participants eager to share their insights.

    Mar 6, 2025

  • AstraZeneca Scaling Up Use of Generative AI to Help Reach 2030 Ambitions

    Clinical Research News | Generative artificial intelligence is being used by AstraZeneca to expedite its five-year ambitions to be an $80 billion company, deliver 20 new medicines, and be carbon negative. The initial value-driving activities include the creation of AI assistants to help with 3D location detection on CT scans and facilitate knowledge extraction for clinical documents as well as an intelligent protocol tool built in partnership with medical writers.

    Feb 4, 2025

  • Thermo Fisher Lupus Registry, Major Partnerships, Glaucoma Testing, More

    Clinical Research News | Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry; MedTech Innovator announced new industry partners; Seonix Bio announced the US launch of SightScore for primary open-angle glaucoma; and more.

    Feb 27, 2025

  • Follow the Money: Rare Muscle Disease Treatment, Huntington’s Disease Trial, More

    Clinical Research News | Abcuro is advancing to a Phase II/III trial to treat a rare, chronic inflammatory muscle disease called inclusion body myositis; Atalanta Therapeutics plans to start Phase I clinical trials of the company’s RNAi therapies for a genetic form of childhood epilepsy and for Huntington’s disease; and more.

    Feb 26, 2025

  • Regulators Support ‘Pragmatism’ in Clinical Trials

    Clinical Research News | A panel of experts from inside several major pharma companies discussed regulatory initiatives around pragmatic trials in depth at the recent Summit for Clinical Trial Ops Executives (SCOPE). Henry Wei, M.D., head of development innovation at Regeneron; Gracy Crane, international regulatory policy lead for real-world data at Roche Products Limited; Melodi J. McNeil, director of regulatory policy and intelligence at AbbVie; Stephanie Derbyshire, clinical operations portfolio leader at Roche; and Kevin Bugin, associate vice president of global regulatory policy and intelligence at Amgen were all part of the panel.

    Feb 25, 2025

  • Scope of Things: SCOPE 2025, Participant Engagement Award Winners, AI Helping With Clinical Trials, More

    Clinical Research News | In this month's episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, an inert gas being tested as an Alzheimer’s treatment, and more.

    Feb 21, 2025

  • USC to Use Generative AI to Make Cancer Clinical Trials More Efficient

    Clinical Research News | The Norris Comprehensive Cancer Center, owned and operated by the University of Southern California (USC) through its Keck School of Medicine, will serve as the initial testing ground for a platform powered by generative artificial intelligence (AI) that is designed to streamline clinical trial operations. This is the first U.S.-based academic site in the research network of California startup company Ryght.

    Feb 20, 2025

  • Fraud and Misconduct in Clinical Trials Not a Trivial Matter

    Clinical Research News | In a debate at the recent Summit for Clinical Ops Executives (SCOPE) over whether fraud and misconduct in clinical trials represent a marginal nuisance or a major problem, the argument for it being a serious situation easily won the day based on a show of hands in the room. Making the case for an embarrassment of breaches was Jonathan Rowe, head of R&D quality, operations and risk management at management consulting and technology firm ZS.

    Feb 18, 2025

  • Why the Human Touch is Still Present in the Technological Era

    Clinical Research News | The healthcare industry has experienced tremendous growth in the use of artificial intelligence (AI) and large language models (LLMs) over the past decade, both of which are already impacting how precision medicine is applied. AI plays a key role in identifying patterns within complex datasets, improving accuracy, and facilitating the exploration of vast volumes of clinical and ‘omics-based research data.

    Feb 14, 2025

  • Crosstree Capital Partners’ Shane Senior Discusses AI’s Disruption of Clinical Trials

    Clinical Research News | At the Venture, Innovation and Partnering forum at last week’s SCOPE Summit in Orlando, Shane Senior, the Managing Director and Owner of Crosstree Capital Partners, delivered a bit of an ultimatum: evolve or die! While the decentralized trial revolution never quite materialized, the AI revolution underway in clinical trials is poised for more dramatic change than ever in the next five years.

    Feb 12, 2025

  • Walgreens Clinical Trials Puts Focus on Patient ‘Readiness’ for Recruitment

    Clinical Research News | Incorporating the lived experience of patients into strategic planning around clinical trials, and outreach to historically under-represented communities, are central features of the operational model of Walgreens Clinical Trials. The key is to foster a sense of trust and long-term connection with different population groups—not show up suddenly and unexpectedly with a flashy recruitment campaign that is destined to “fall flat.”

    Feb 11, 2025

  • Anju, Biorce, Medidata, Phastar Take Home Best of Show Awards from SCOPE 2025

    Clinical Research News | Winners were named in the 2025 SCOPE Best of Show Awards yesterday. With more than 60 new product finalists on display on the Exhibit Hall floor and more than 300 attendees voting on their favorite new products, the Best of Show program at SCOPE highlights the very best in innovation and new technologies in clinical research.

    Feb 6, 2025

  • Narrowing the Gap Between Clinical Research and Clinical Care

    Clinical Research News | The growing convergence between clinical research and clinical care—and ways the second Trump administration will be encouraging and supporting movement in that direction—was the topic of the opening keynote presentation made at this week’s Summit for Clinical Ops Executives (SCOPE) in Orlando.

    Feb 5, 2025

  • Grove AI Named the 2025 Participant Engagement Award Winner

    Clinical Research News | In a contest focused on the finalist themes of AI (artificial intelligence), DEI (diversity, equity and inclusion), and community engagement, a winner was chosen to be the 9th Annual Participant Engagement Award during opening ceremonies yesterday at the Summit for Clinical Ops Executives in Orlando. This year’s top honor went to Grove AI for personalizing participant recruitment and engagement at scale using a smart bot named Grace acting as a clinical research assistant.

    Feb 4, 2025